We have shown previously that a low-molecular-weight fucan extracted f
rom the brown seaweed Ascophyllum nodosum strongly inhibited human com
plement activation in vitro and its mechanism of action was largely el
ucidated. We further investigated the influence of molecular weight an
d chemical composition of fucan on its anticomplementary activity. The
capacity of 12 fragments of fucan (ranging from a molecular weight of
4100 to 214 000) to prevent complement-mediated haemolysis of sheep e
rythrocytes (classical pathway) and of rabbit erythrocytes (alternativ
e pathway) increased with increasing molecular weight, and reached a p
lateau for 40 000 and 13 500, respectively. The most potent fucan frac
tions were 40-fold more active than heparin in inhibiting the classica
l pathway. They were, however, as active as heparin in inhibiting the
alternative pathway. In addition, we have developed a haemolytic test
based on the CH50 protocol, which allows discrimination between activa
tors and inhibitors of complement proteins. Although the mannose conte
nt within the different fucan fragments did not vary, the galactose an
d glucuronic acid contents increased with increasing activity, suggest
ing that these residues should be essential for full anticomplementary
activity. Meanwhile, sulphate groups appeared to be necessary, but we
re clearly not a sufficient requirement for anticomplementary activity
of fucans. Taken together, these data illustrate the prospects for th
e use of fucans as potential anti-inflammatory agents.